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Abstract
Background: Medical symptoms independent of body location burden individuals to varying degrees and may
require care by more than one expert. Various paper and computer-based tools exist that aim to comprehensively
capture data for optimal clinical management and research.
Methods: A web-based interdisciplinary symptom evaluation (WISE) was newly designed, constructed, and technically
implemented. For worldwide applicability and to avoid copyright infringements, open source software tools and free
validated questionnaires available in multiple languages were used. Highly secure data storage limits access strictly to
those who use the tool for collecting, storing, and evaluating their data. Concept and implementation is illustrated by a
WISE sample tailored for the requirements of a single center in Switzerland providing interdisciplinary care to orofacial
pain and temporomandibular disorder patients.
Results: By combining a symptom- burden checklist with in-depth questionnaires serving as case-finding instruments,
an algorithm was developed that assists in clarifying case complexity and need for targeted expert evaluation.
This novel modular approach provides a personalized, response-tailored instrument for the time- and cost-effective
collection of symptom-burden focused quantitative data. The tool includes body drawing options and instructional
videos. It is applicable for biopsychosocial evaluation in a variety of clinical settings and offers direct feedback by a case
report summary.
Conclusions: In clinical practice, the new instrument assists in clarifying case complexity and referral need, based on
symptom burden and response –tailored case finding. It provides single-case summary reports from a biopsychosocial
perspective and includes graphical symptom maps. Secure, centrally stored data collection of anonymous data
is possible. The tool enables personalized medicine, facilitates interprofessional education and collaboration,
and allows for multicenter patient-reported outcomes research.
Keywords: Personalized medicine, Patient-reported outcome measures, Orofacial pain, Temporomandibular
disorders, Questionnaire
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Background
Primary, secondary and tertiary care providers may all
be involved in the diagnosis and management of symp-
toms related to tissue dysfunction and pain disorders.
Gathering valid and reliable data in all types of clinical
setting is essential for high-quality personalized care and
research [1]. Patient self-report data are increasingly rec-
ognized as a valuable resource for this purpose. Yet, in
the context of patient consultations, it is often difficult
to systematically and prospectively collect high-quality
data. This aspect is further complicated in studies that
aim to comprehensively assess physical and psychosocial
parameters, e.g., functionality, pain interference, beliefs
and expectations; pain catastrophizing, social roles, func-
tioning, and interactions; emotional distress, and sleep.
The seminal 1992 publication of the Research Diag-
nostic Criteria for Temporomandibular Disorders (RDC/
TMD) and the subsequent refinement in the form of
Diagnostic Criteria for Temporomandibular Disorders
(DC/TMD) in 2014 represented a paradigm shift in the
evaluation and diagnosis of patients with TMD, a hetero-
geneous group of disorders affecting the jaw joint and
surrounding tissues [2, 3]. The most salient novel feature
contrasting with previous TMD diagnostic systems was
the introduction of the biopsychosocial model into den-
tal medicine. This concept includes not only the assess-
ment of somatic signs and symptoms (Axis I) but also
the biobehavioral domain (Axis II). The screening of pa-
tients for psychosocial burdens aimed to appropriately
refer patients for expert assessment and interventions to
address non-somatic barriers to TMD recovery. Subse-
quent prospective cohort studies supported the clinical
utility of Axis II instruments [4–6]. Psychosocial factors
have the potential to affect treatment responses not only
of OFP and TMD sufferers, but of many types of chronic
pain [7–9]. Management of diverse biopsychosocial is-
sues and/or comorbidities is relevant for some — but
not all — individuals experiencing OFP and TMD. Thus,
individuals seeking health care vary greatly in their
subjective complaints, personal histories, and comorbid
conditions. The diverse clinical symptoms of identical
pathologies may be attributable to differing environmental,
psychosocial, and genetic factors. Common approaches for
profiling patients and phenotyping disorders may include
the following tools: checklists, questionnaires, interviews,
physical examinations, imaging, laboratory tests, and psy-
chological/psychiatric evaluations.
The administration of a barrage of measures can sig-
nificantly increase patient burden and decrease compli-
ance. Recently, data collection methods that are adapted
to a patient’s unique history (rather than a lengthy sur-
vey including questions that would not apply to them)
have become popular [10, 11]. For this purpose, a check-
list can call attention to a symptom and ensure that
nothing of importance is overlooked. Since multiple
somatic and psychological symptoms frequently coexist
in OFP and TMD patients, case-finding instruments
have been developed for initiating diagnostic procedures
that facilitate optimized treatment. For this purpose,
cost- and time-effective questionnaires validated in the
primary care setting exist that are capable to clarify the
need for expert evaluation of individuals possibly suffering
from migraine, tinnitus, anxiety, depression, sleep disor-
ders, etc. A possible way to build a tool for comprehensive
patient assessment is to combine a symptom-burden ori-
ented checklist with various in-depth questionnaires
serving as case-finding instruments.
Traditionally, data collected via paper-based question-
naires can be used for clinical care and research. How-
ever, it is time-consuming and costly to extract their
data. Paper-based questionnaires are often disliked by
patients, data are sometimes unreadable, and missing
items are challenging for statistical data analysis [12].
Among others, the US Institute of Medicine advocates
using information technology to support patient-centered
care and evidence-based decisions [13, 14]. Electronic
healthcare records are increasingly implemented in many
countries. E.g., in the U.S., a Medicare and Medicaid
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Electronic Health Care Record Incentive Program was
recently established to encourage widespread adoption
of an electronic health record [15]. Capturing patient
reported information electronically results in a more
accurate and complete data set, improved protocol
compliance, avoidance of secondary data entry errors,
easier implementation of skip patterns, less administra-
tive burden, high respondent acceptance, reduced sam-
ple size requirements, and potential cost savings. The
increasing number of patients who are already familiar
and comfortable with electronic devices are likely to
prefer this format of delivery [16]. Health information
technology (health IT) enables the collection of large
amounts of patient care data in electronic form, but
this requires new architectures, techniques, algorithms,
and analytics for data management and for extracting
knowledge [17]. In the U.S., a collaborative health out-
comes information registry (CHOIR) is currently being
built from patient data provided by US American care
centers [18]. The structure and composition of its ques-
tions addressing OFP and TMD, its algorithm, and its
scoring system are, however, not publicly available.
The goal of this project was to design, construct, and im-
plement a modular, universally accessible, web-based in-
strument for interdisciplinary symptom evaluation (WISE)
for subject-tailored assessment of OFP and TMD prior to
clinical interviews. We aimed to clarify symptom-burden
by a checklist and with case-finding instruments in the
form of publicly available, in-depth questionnaires to cre-
ate response-tailored assessments. Copyright issues were
avoided and a highly secure data storage location free of
third party interests was selected.
Methods
Open source software tools
LimeSurvey™ (LS)
To design and construct the WISE for OFP and TMD, we
used LimeSurvey™ 2.05+ (150310), which is a platform-
independent open source framework for the development
of internet based surveys [19]. LS runs on any web server
and the data is stored in a MySql database. To ensure
privacy, data can be transmitted via secure https. As a sur-
vey framework, LS contains predefined response formats
including single and multiple choice, array responses, and
equations. Equations enable calculation of scores that
serve as filters to stratify for additional in-depth questions.
LS implements the construction of multilingual surveys.
Data can be exported in different formats, such as SPSS,
Excel, and others.
ImageMapster (IM)
IM is a JQuery-based tool for using image maps for data
entry [20]. Predefined areas of a background image can
be selected to graphically represent pain on a body
schematic. IM can easily be included in the LS question
code. In the WISE, IM was used for the assessment of
OFP location and severity.
Data security and storage
Maintaining participant privacy is critical. The WISE can
run on any highly secure webserver. Data security and
storage can be managed in a single country or on wide-
spread servers. For optimal data security, data linked to
patient identity are stored independent of survey data.
The latter are stored in anonymized form on a highly se-
cure central server, whereas patient identity data are
stored locally in clinics or centers. Single-case summary
reports are generated by linking local and central data via
a unique identification number (ID). In this process, the
only data exchanged is an anonymous ID and anonymized
survey data (SDATA). During initial data collection, the
authors managing patients at the Orofacial Pain Unit of
the Center of Dental Medicine, University of Zurich
(UZH) established a central secure host at Service and
Support for Science IT of the UZH, adhering to Swiss
federal and cantonal laws for privacy protection.
Figure 1 illustrates the current setup at the University
of Zurich, Switzerland.
WISE concept, structure and content
The WISE was designed to assist clinical decision making.
A key requirement was the ability to capture symptoms
that are commonly experienced by patients reporting to a
given health care provider setting. In order to illustrate the
pragmatic implementation of this technical tool and its
underlying concept, we present a WISE sample structure
tailored for the requirements of the interdisciplinary orofa-
cial pain unit at the University of Zurich, Switzerland,
where patients seek care for a broad variety of muscu-
loskeletal, neuropathic and idiopathic orofacial pains
conditions. From a technical-methodological perspec-
tive, adapting the software to satisfy various content
requirements of similar or other settings is easily ac-
complished owing to the tool’s modular and modifiable
design.
Conceptually, the WISE was structured to assess pa-
tients in three stages: 1) assessment of symptom burden
by a checklist, 2) response-tailored in-depth analyses of
burdening symptoms by case-finding validated question-
naires, and 3) targeted expert evaluation(s) of burdening
symptoms identified as likely being part of a defined
condition.
Importantly, the term “symptom” relates to the sub-
jective experience of an unusual state (abnormal func-
tion or feeling) that is not directly measurable. Making
perceptual decisions and classifying bodily sensations as
possibly harmful is an inherent part of interoception
which influences the subjective experience of symptom-
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related burden [21]. E.g. a headache may be painful, but
perhaps not sufficiently burdening the person to take
medication. Analogously, a jaw joint sound due to an an-
terior disc displacement with reduction may be slightly
annoying to some people, yet highly burdening to others.
Uncertainty about the harmfulness of bodily sensations
typically influences the individually perceived symptom
burden [22]. It is for these reasons that the WISE check-
list focuses on degree of somatic and psychological
symptom burdens. Whether burdening symptoms are
part of an expert defined condition can be further
evaluated by in-depth questionnaires which serve as
validated case-finding instruments for clarification.
Clinicians are thereby alerted about the possible indi-
cation for further interdisciplinary expert evaluation
The latter may involve more refined validated instru-
ments such as e.g. a structured clinical interview and/
or validated clinic assessment for establishing a diag-
nosis according to DC/TMD, International Classifica-
tion of Headache Disorders, Diagnostic and Statistical
Manual of Mental Disorders, etc.
Questionnaires by which checklist content was thematically
aligned
Co-existence of multiple somatic and psychological
symptoms is prevalent in OFP and TMD patients. For
heuristic purposes, the item content of the WISE symp-
tom burden checklist was thematically aligned with ques-
tionnaires commonly addressing these diverse symptom
domains. Notably, the adaptation of items and/or of entire
questionnaires resulted in the loss of their originally vali-
dated psychometric properties. The symptom burden
checklist items were taken as is or adapted from the
following instruments.
DC-TMD Symptom Questionnaire (DC-TMD-SQ)
The DC-TMD-SQ has 14 items and is part of the DC/
TMD algorithms, the validity of which is presented in
Schiffman et al. [3]. It inquires about the presence of
common symptoms associated with OFP and TMD.
Patient Health Questionnaire 15 (PHQ-15) The PHQ-
15 evaluates the severity of somatic symptoms [23]. It
was never intended to diagnose a specific clinical entity.
PHQ-Stress PHQ-Stress is a 10-item subscale of the
Primary Care Evaluation of Mental Disorders (PRIME-
MD) Patient Health Questionnaire that addresses
burden by psychosocial stress [24].
Validated case-finding questionnaires
The following questionnaires clarify whether burdening
symptoms are part of an expert defined condition and
thus assist clinicians in identifying patients that might
benefit from further targeted expert evaluation. Informa-
tion on their coefficient alpha and test-retest reliability
has been included when published.
Patient Health Questionnaire 4 (PHQ-4) The PHQ-4
screens for anxiety and depression in primary care pa-
tients [25, 26]. It consists of two subscales GAD-2 (item
1 and 2 of the General Anxiety Disorder Questionnaire
7) and PHQ-2 (item 1 and 2 of the Patient Health Ques-
tionnaire 9). Items are scored on a four-point ordinal
rating scale. Scores can be calculated for the two



























Fig. 1 Overview of data exchange options between multiple patient management centers and a secure central data collection server. For clinical
practice, customized single case reports available only to the supplying clinic are generated from centrally stored data that are linked by a unique
identification number (ID). For research purposes, anonymized data clusters can be merged, thus enabling multicenter research projects
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subscales (maximum score = 6) as well as overall (max-
imum score = 12). Total scores of 6 to 8 or subscale
scores of 3 to 4, respectively, indicate a possible disorder
(“yellow flag”). Total scores above 8 or subscale scores
above 4, respectively, are suggestive of a probable dis-
order (“red flag”). The following coefficient alpha have
been reported: PHQ-4: 0.87; PHQ-2: 0.75; GAD-2: 0.82
[25], and for test-retest reliability: PHQ-4: 0.81; PHQ-2:
0.77; GAD-2: 0.69 [27].
General Anxiety Disorder Screener 7(GAD-7) The
GAD-7 assesses general anxiety in primary care patients
[28, 29]. High correlations with disability measures were
found [30]. Seven items covering different aspects of
general anxiety are scored (using the same scale as the
PHQ-4). Summary scores range from 0 to 21 and indi-
cate anxiety levels of “none/minimal” (0–4), “mild” (5–
9), “moderate” (10–14), or “severe” (>14). The following
coefficient alpha has been reported: 0.92 and fortest-
retest reliability: 0.83 [31].
Patient Health Questionnaire 9 (PHQ-9) The PHQ-9
assesses severity of depression [32]. Like the GAD-7, it
correlates with functional impairment [30]. Nine items
covering different aspects of depression are scored
(using the same scale as the PHQ-4). Summary scores
range from 0 to 27, indicating depression levels of
“none/minimal” (0–4), “mild” (5–9), “moderate” (10–14),
“moderately severe” (15–19), or “severe” (> 19). A cut-
off score range of 8–11 has been recommended for
expert evaluation referral [31, 33]. The following coeffi-
cient alpha has been reported: 0.89 and for test-retest
reliability: 0.84.
PHQ-Stress The cut-off scores are 10 for “medium”
and >14 for “severe” burden by psychosocial stress
[24]. No coefficient alpha nor test-retest reliability
were reported.
Graded Chronic Pain Scale (GCPS) v2 The GCPS was
originally developed for general population surveys and
primary health care to improve prognostic categorization
and treatment decisions [34]. Its prognostic validity in
OFP and TMD research has been supported: Higher
GCPS ratings are a risk factor for pain chronicity [4].
For clinical decision-making, matching TMD pain-
related disability levels with appropriate treatment has
been recommended [35]. GCPS consists of seven items
measuring pain intensity and related disability, which
were scored independently. The maximum disability
score is six. Scores of 3–4 are interpreted as moderate
impairment and 5–6 as severe impairment. The 90 days
version of the scale was implemented for the WISE. The
following coefficient alpha has been reported: 0.71 for
TMD pain, test-retest reliability has not been reported.
Pain Catastrophizing Scale (PCS) The PCS assesses
catastrophizing thoughts and corresponding behavior
[36]. Its 13 items were rated on a 5-point ordinal rating
scale. The maximum score is 52, with a cut-off score of
30 [36]. The following coefficient alpha has been re-
ported: 0.87 and for test-retest reliability: 0.75.
Insomnia Severity Index (ISI) The ISI screens for sleep
disorders by measuring the severity of insomnia prob-
lems, sleep-related satisfaction, and interference. Items
were rated on a 5-point ordinal rating scale. The max-
imum score is 28, with a cut-off score of 14 [37–40].
The following coefficient alpha has been reported: 0.74,
test-retest reliability was not reported.
Brief Illness Perception Questionnaire (B-IPQ) The
B-IPQ assesses cognitive and emotional representations
of illness and health threat [41, 42]. Eight questions cov-
ering different aspects of illness perception were rated
on a numeric rating scale ranging from 0 to 10. No cut-
off score has been reported. Test-retest reliability of the
single items of the B-IPQ range from .48 to .70, a coeffi-
cient alpha value was not reported.
Injustice Experience Questionnaire (IEQ) The IEQ
assesses injustice experienced due to accidents, injur-
ies, or maltreatment [43]. Twelve items, which reflect
the frequency of thoughts, beliefs, and emotions asso-
ciated with injury, were rated on an ordinal scale ran-
ging from 0 to 4. The maximum score is 48, with a
cut off score of 30 representing a clinically relevant
level of perceived injustice [30]. The following coeffi-
cient alpha has been reported: 0.92 and for test-retest
reliability: 0.90.
Dysmorphic Concern Questionnaire (DCQ) The DCQ
assesses excessive preoccupation with imagined or ac-
tual, minimal defects in appearance that significantly in-
fluence psychosocial functioning [44, 45]. It consists of
seven items, rated on an ordinal scale ranging from 0 to
3. The maximum score is 21 with cut off score of 9 sug-
gesting a possible body dysmorphic disorder [44]. The
following coefficient alpha for the DCQ has been re-
ported: 0.85, test-retest reliability was not reported.
Tinnitus Handicap Inventory (THI-12) The 12-item
THI assesses tinnitus severity and its impact on daily life
[46]. The summary score ranges from 0 to 24 indicating
following levels of impairment by tinnitus: 0–6 denotes
“no handicap”, 7–10 “mild handicap”, 11–14 “moderate
handicap”, and >14 “severe handicap”. The following
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coefficient alpha has been reported: 0.88 and for test-
retest reliability: 0.89.
Identification of Migraine (ID-Migraine™) screener
The three-item ID-Migraine™ screens for migraine head-
ache [47, 48]. An affirmative response to two of three
items discriminates migraine from other headaches. No
coefficient alpha or test-retest reliability was reported for
this instrument.
Other symptom exploration instruments
Jaw Function Questionnaire (JFQ) The JFQ is a check-
list of 12 daily jaw activities for assessing OFP and TMD
related disability [49]. It was part of an earlier version of
instruments to assess axis-II disorders of the RDC/TMD
consortium. It was preferred over the Jaw Function Limi-
tation Scale because the latter contains items unsuitable
for vegetarians/vegans, leading to cultural bias. The an-
swer options were expanded to “no” (=0), “a little” (=1),
and “a lot” (=2) to better assess the impact of limita-
tions. No diagnostic cut-off value applies. We added
two measures for quantitative evaluation: 1) “jaw func-
tion” on a scale ranging from “normal function” (0) to
“no movement possible” (10) and 2) “dietary restric-
tions” on a scale ranging from “no restrictions” (0) to
“liquid only” (10) [50].
Somatosensory symptom checklist (SSC) Somatosen-
sory facial alterations are not systematically captured in
orofacial pain questionnaires. For the WISE for OFPand
TMD, we integrated an eight-item checklist that is used
to assess posttraumatic neurosensory deficits or altered
function [51]. No cut-off value applies.
Administration
After receiving a referral email or letter, the clinic admin-
istrator registers the patient in a database. The login infor-
mation for the WISE is sent to the patient by letter. Upon
opening the survey, patients receive information about its
purpose, duration, and privacy protection. Instructions,
including short video-clips, are available for assistance.
Upon submitting the questionnaire, a patient will be con-
tacted by the clinic administration in order to schedule an
appointment. This is the way that our clinic uses the
WISE, but any different implementation is possible.
Results
Similar to a patient chart, the WISE captures information
according to the following structure:
1) General information/patient characteristics
(gender, age, height, weight, known allergies,
social and parafunctional habits, primary care and
referring clinician, occupational status);
2) Chief complaint(s) and modulating factors;
3) Symptom burden checklist and related in-depth
questionnaires;
4) Previous diagnoses and effects of prior treatments;
5) Privacy policy, informed consent.
General structure and scoring of the symptom burden
checklist
The checklist begins with items addressing symptom
burden in various extra- and intraoral locations. Add-
itional checklist items were included for comprehensive
orofacial symptom assessment such as xerostomia, hali-
tosis, dysphagia, tooth/jaw related dysmorphophobia,
and obstructive sleep apnea. Pain-related questions were
grouped by body areas. Checklist-item scoring was
structured according to the PHQ-15 by grading the
symptom-related burden.
Thresholds for presenting case-finding tools and in-depth
questions
Thresholds for presenting case-finding tools and in-
depth questions can be adjusted, depending on particu-
lar clinic or research focus. Here, we suggest a low
threshold for pain-related checklist items and a higher
threshold for others. I.e., patients who check being both-
ered at least ‘a little’ for one or more pain items were
offered additional in-depth questions which focus on
capturing graphically pain location and intensity in the
following areas: head/face, torso, and elsewhere on the
body. Further questions address pain quality, onset, dur-
ation, time pattern, diurnal course, and pain-related dis-
ability (Table 1 and section Pain severity and location).
The threshold is set to ‘bothered a lot’ for the presenta-
tion of the following case-finding tools: PHQ-9, GAD-7,
IPQ, PCS, DCQ, IEQ, PHQ-S, THI-12, ISI.
Assembly of the WISE items (see Table 1 and 2)
DC-TMD Symptom Questionnaire (DC-TMD-SQ)
The DC-TMD-SQ consists of checklist items (items 1, 5,
8, 9, 13) and related in-depth sub items (items 2, 3, 4, 6,
7, 10, 11, 14).
Content of DC-TMD-SQ item 1 (pain in the jaw, tem-
ple, in the ear, or in front of the ear) was split into
checklist items 2 and 3. Content of DC-TMD-SQ items
5 (headache) and 8 (joint noises) were added unaltered
to the checklist. Content of DC-TMD-SQ item 9 (closed
locking of the jaw) and item 13 (open locking of the jaw)
were grouped into checklist item 5. The recall period for
symptom presence was limited to 30 days, consistent
with other checklist items.
The content of DC-TMD-SQ items 2, 3, and 6 were
placed in the in-depth pain exploration section (see sec-
tion Pain duration and Time pattern). Content of DC-
TMD-SQ sub items 4 and 7 were covered in the JFQ,
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which focuses on disabling rather than aggravating as-
pects of OFP and TMD. Finally, content of DC-
TMD-SQ sub items 10, 11 and 14 (corresponding to
DC-TMD-SQ checklist items 9 and 13) were omitted
because these aspects were considered better explored
in the clinical interview.
Patient Health Questionnaire 15 (PHQ-15)
In OFP and TMD sufferers somatization is prevalent in
primary care [52]. Importantly, the PHQ-15 items were
not used as a measure of somatization severity according
to its original publication [30]. Rather than using the
PHQ-15 as a validated questionnaire, its item content
was included in the checklist to coarsely assess the bur-
den of physical/bodily symptoms beyond OFP AND
Table 1 WISE items and checklist content sources, case-finding tools and other symptom exploration instruments




1) Toothache/oral pain (e.g., tongue, gums) none
2) Pain/tightness in the jaw or face DC-TMD-SQ:1
3) Ear pain, ear pressure, tinnitus (e.g., ringing noise) DC-TMD-SQ:1 a little THI-12
4) Headache DC-TMD-SQ:2 a little ID-Migraine Screener
Σ(1..4) 1 PAIN-head/face
GCPS-head/face
5) Limitation/pain upon mouth opening or closing (e.g. yawning) DC-TMD-SQ: 9 & 13 a lot modified JFQ
6) Limitation/pain upon biting/chewing/talking/drinking DC-TMD-SQ: 4 & 7 a lot modified JFQ
7) Temporomandibular joint (TMJ) noises (e.g., clicking, crepitus) DC-TMD-SQ:8 a little clicking
crepitus
other
8) Tooth/jaw position (e.g., bite is incorrect)/physical appearance none a lot DCQ
9) Abnormal sensations in the mouth, lips or face that have negative
effects (e.g., uncontrolled drooling)
SSC a lot SSC, modified JFQ
10) Dry mouth/malodor/swallowing difficulties none
Other pain 11) Pain in the neck/shoulder none
12) Pain in the back area PHQ-15:2
13) Pain in the chest/abdomen/genitals PHQ-15:1,4,6 & 11 a little PAIN-torso
14) Pain in the arms, legs PHQ-15:3
Σ(11,12,14) 1 GCPS-B
PAIN-body
Other symptoms 15) Worries about my chief complaint(s) PHQ-S:1 a lot B-IPQ, PCS
16) Increased fatigue/loss of energy/unintentional weight loss or gain PHQ-15:14 a lot PHQ-9
17) Snoring/apnea during sleep none
18) Dizziness/nausea/fainting spells/shortness of breath/feeling your heart
pound or race/indigestion
PHQ-15:7–10,13 a lot PHQ-S
19) Lack of time/work related stress/caring responsibilities/finances PHQ-S:5–7 a lot PHQ-S
20) Lack of support/interpersonal conflicts/loneliness PHQ-S:4,8 a lot PHQ-S
21) Different opinions of different caregivers/not been taken seriously none a lot IEQ
22) Stressful life events (something bad that happened recently or in the
past with corresponding thoughts/dreams/feelings)
PHQ-S:9,10 a lot PHQ-S
Table 2 PHQ-4 screening items and thresholds for related case-
finding tools. A value of >2 (yellow flag) was chosen for a further
evaluation by GAD-7 and by PHQ-9. For item 27, a value of >1 was
used as threshold for presenting the ISI
Checklist item (continued) Source Threshold In-depth assessment
23) Feeling nervous, anxious
or on edge
GAD-2 Σ > 2 GAD-7
24) Not being able to stop
or control worrying
25) Little interest or pleasure
in doing things
PHQ-2 Σ > 2 PHQ-9
26) Feeling down, depressed,
or hopeless
27) Trouble falling or staying
asleep, or sleeping too
much
PHQ-9 > 1 ISI
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TMD (see Table 3). E.g., content of PHQ-15 items 1
(stomach pain), 4 (menstrual cramps or other problems
with your periods), 6 (chest pain), and 11 (pain during
sexual intercourse or other sexual problems) were
slightly modified to focus on pain and grouped into
checklist item 13. Content of PHQ-15 items 7 (dizzi-
ness), 8 (fainting spells), 9 (feeling your heart pound or
race), 10 (shortness of breath), and 13 (nausea, indiges-
tion) were grouped into WISE checklist item 18, to
screen for symptoms associated with autonomic dys-
function. PHQ-15 item “trouble sleeping” was replaced
by content of item 3 of PHQ-9 item “trouble falling or
staying asleep, or sleeping too much.” Because of the
analogous scoring, it was placed after the PHQ-4 section
in the checklist. We considered the PHQ-9 item content
more appropriate since it covers a broader spectrum of
sleep problems.
PHQ-Stress
The content of PHQ-Stress items were transformed into
checklist items, to screen for psychosocial stressors.
Content of PHQ-Stress item 2 (your weight or how you
look) was covered by checklist items 8 and 16. Content
of PHQ-Stress item 3 (little or no sexual desire or pleas-
ure during sex) was covered by checklist item 13. Con-
tent of PHQ-Stress items 5 (stress of taking care of
children, parents, or other family members), 6 (stress at
work outside of the home or at school), and 7 (financial
problems or worries) were grouped into checklist item
19. Content of PHQ-Stress items 4 (interpersonal con-
flicts) and 8 (lack of support/loneliness) were grouped
into checklist item 20. Content of PHQ-Stress items 9
(something bad that happened recently) and 10 (thinking
or dreaming about something terrible that happened to
you in the past) were grouped into checklist item 22.
Table 3 Publicly available questionnaires used in the construction of the WISE for OFP and TMD
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7–12 [31, 33, 73–75]









































Jaw function Modified Jaw Function




















Somatosensory dysfunction Somatosensory Symptom Checklist
(SSC) [51]
Checklist 0–7 n/a
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Content of items 2 and 3 were not integrated into
checklist because their content was already covered by
other checklist items.
Patient Health Questionnaire 4 (PHQ-4)
The PHQ-4 was implemented in its original version, ex-
cept that the recall period was adapted to “over the last
30 days,” for covering the same time interval in all WISE
assessments. The sleep item of PHQ-9 was added below
the PHQ-4 due to the analogous scoring.
Optional checklist items
Patients experiencing ongoing pain associated with inva-
sive procedures may experience feelings of injustice.
Additionally, some patients may feel that they are a bur-
den to others. For screening purposes, these aspects
were captured by the two items listed in Table 4.
Depending on the needs of a given clinic or research
focus, additional items can be included. In addition to
the items listed in Table 4, further examples are listed in
Table 1 (items 10, 11, 17 and 21).
Pain related in-depth questions
Upon exceeding a predefined checklist threshold value,
the following items were presented.
Pain severity and location
Various tools measure pain severity. We chose the NIH
Toolbox as it is widely accepted. It uses an 11-point in-
tensity rating scale with anchors 0 (“no pain”) and 10
(“worst imaginable pain”) [53]. For consistency, we im-
plemented these anchors in the entire WISE.
For different regions of the head, face, and mouth,
pain intensity during the last 4 weeks was assessed
using a pain-drawing tool. On an image of the head
and oral cavity, predefined regions relating to under-
lying anatomical structures could be selected with a
mouse-click (e.g., masticatory muscles, teeth; Fig. 2).
IM was used to make these areas selectable and to
color selected regions, with darker red denoting greater
pain intensity. Patients first click on the area of the
most burdensome pain, which revealed a dialog querying
the most frequent pain intensity at rest and maximum
pain intensity on jaw movement.
Pain quality
Pain quality was characterized by the descriptors
(Schmerzbeschreibungsliste; SBL) of the German pain
questionnaire (Deutscher Schmerzfragebogen; GPQ).
The list was supplemented with adjectives that capture
distinct OFP perceptions [54, 55]. Patients were requested
to choose which of 15 pain descriptors described their
typical current pain and pain at illness onset. The list
included nine sensory pain adjectives (“dull-pressing,”
“pulling,” “stinging,” “pulsating-throbbing,” “burning-hot,”
“pins and needles,” “shooting-electric,” “tingling,” “numb”)
and six affective pain adjectives (“dreadful-horrible,” “mis-
erable-atrocious,” “exhausting,” “grueling,” “agonizing,”
“frightening”). The option “other pain quality” allowed pa-
tients to add descriptors that were otherwise not covered.
Pain duration
Because the time value that defines chronic pain varies
from 3 to 6 months, we added an interval ranging
from 3 to 6 months to the classification used in the
GPQ [54, 56]. We included the following time inter-
vals: “up to 3 months,” “more than 3 up to 6 months,”
“more than 6 months up to 2 years,” “more than
2 years up to 5 years,” and “more than 5 years.”
Time pattern
For the most burdensome pain, time variation was
assessed by one of four different patterns, according to
the GPQ [54] (Fig. 3). Patients chose the time pattern
that best matched their typical pain course. If pattern 2,
3, or 4 was chosen, the following item was presented:
“Please indicate the intensity of the most frequent max-
imum pain during the last 4 weeks.” Choosing pattern 3
or 4 was followed by the items: “How often do these at-
tacks typically occur while awake? (number of attacks
per 24 h)”, “How often do these attacks typically occur
while sleeping? (number of attacks per 24 h)”, “Which is
the typical duration of your attacks?” and “The attacks
are triggered by …?”.
Diurnal pain course
For the most burdensome pain, seven sliders were used
to represent the most frequently experienced intensity
during 3-hour intervals throughout the day and one 6-h
interval at night (Fig. 4). Because maximum pain severity
was already captured in section Pain severity and loca-
tion (Fig. 2), the “most frequent” pain was considered
more relevant in this context. The ill-defined term “aver-
age” pain intensity was intentionally avoided.
Onset of pain
Possible reasons for the onset of pain were captured by
a single-choice checklist with the options a) “gradual,”
b) “sudden,” c) “by event (accident, physical/emotional
Table 4 Checklist items capturing aspects of injustice experience
and being a burden to others
Checklist item (continued) Source Threshold In-depth
assessment
28) Did you experience injustice




29) Are you concerned about being a
burden to others?
none yes B-IPQ
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stress, dental/medical treatment, operation, illness),”
and d) “other.” If applicable, further sub-items explored
the date of first memorable occurrence and the exact
nature of events.
Single case summary report
Single case summary reports varied in length, depending
on case complexity. We present two examples of the
computer-generated data assembly in Figs. 5 and 6. Note
that the report is interactive. Detailed results of in-depth
questionnaires can be displayed by moving the cursor over
selected areas of images or over theⓘ button.
Language options
Multilingual surveys are optional in LS.
Discussion
Francis W. Peabody opined that “the secret of the care
of the patient is in caring for the patient” [57]. Today,
health IT offers new ways of identifying patient needs by
comprehensively assessing the varied biopsychosocial
factors that influence the experience of pain and other
symptoms. From a conceptual point of view, the WISE
prioritizes the subjective symptom burden. Many symp-
toms in the orofacial regions differentially burden individ-
uals such as jaw joint noises, feeling of tension in the
masticatory muscles, C-shaped jaw deviation, etc. Whereas
they are barely bothersome to some people, they can be
majorly burdening to others. This experiential disparity is
often linked to psychological comorbidities unidentified in
the primary (dental) care setting. In many everyday clinical
Fig. 2 Pain drawing. The predefined areas are marked with green dotted lines. Pain intensity of selected regions is represented by gradients of red.
Darker red indicates more intense pain
Fig. 3 Time pattern of pain. Patients can select one of four different patterns
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situations, patient management will be symptom oriented
and the indication for interdisciplinary (e.g. psychological)
evaluation will depend mostly on symptom burden. Com-
monly the therapeutic strategy for patients suffering from
musculoskeletal, neuropathic or idiopathic pain in the oro-
facial region is targeted towards symptom relieve rather
than elimination of etiologic factors as these are often un-
known. Thus, the WISE supports clinical decision making
in clinical practice aiming at identifying patients’ needs
(based on symptom burden) for optimal care, possibly in-
cluding an interdisciplinary approach.
The scoring of WISE checklist items focuses on
symptom-related burden, per J. D. Loeser: “It is suffer-
ing, not pain, that brings patients into doctor’s offices in
hopes of finding relief” [58]. Besides diagnostic perform-
ance, questionnaires are ideally brief, self-administered,
multipurpose, free, and easy to score. All these features
were considered in generating the WISE.
We described in detail the design, construction, and
technical implementation of web-based questionnaire
for assessing patients with OFP and TMD. It was de-
signed to be modular, flexible, extensible, and to include
Fig. 4 Example of a possible diurnal pain course. Each bar represents a 3-h time period during the day and a 6-hour period at night. Most frequent
pain intensity from 0 to 10 is indicated by moving the bars accordingly
Fig. 5 Example of a single case summary report
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drawing options as well as instructional videos. The use
of open-source software tools and freely available ques-
tionnaires prevented copyright infringements. Secure
data storage limits access strictly to those who use the
WISE for collecting, storing, and evaluating their own
data. Although WISE and the US-based CHOIR have
similarities, no available manuscript reports on the
structure and composition of its OFP andTMD ques-
tions, its algorithm, or its scoring system [18].
For patients, a major advantage is that the WISE is
available independent of location; therefore respondents
can provide information without time pressure via any
available computer, on all possible platforms, using any
standard browser, and in different languages. The WISE’s
modular design is highly patient-centered as it enables
personalized assessment of biopsychosocial burden. The
option to stop and restart at any point in time dimin-
ishes the cognitive burden and respondents can easily
review and revise entered data before submission. Re-
spondents are not dependent upon planned, prearranged
clinical appointments.
For care providers and administrative personnel, the
WISE is easy to administer and electronic data are stored
securely. The system can even be used by clinicians who
lack electronic health records. The tool’s modular struc-
ture enables organization of relevant information prior to
patient appointments, thus facilitating time and personnel
management. Namely, information on somatic and psy-
chosocial burdens may clarify the need for interdisciplin-
ary consultation to identify an appropriate expert. The
single case summary report of WISE enables a focused
clinical evaluation that prioritizes the most burdensome
complaints. This likely facilitates caregiver-patient interac-
tions as from the outset the patient feels understood re-
garding his/her chief complaint.
For educators, the WISE can assist interprofessional
education (IPE) in this field [59]. IPE aims to share skills
and knowledge among health care disciplines. WISE case
reports in a teaching environment can illustrate to students
benefits to patients of working within interprofessional
teams [60]. Implementation of such educational models
has been recommended by the Institute of Medicine of the
US National Academies [61].
Clinical researchers benefit from the WISE by having
available standardized data sources. A database is gen-
erated without the need for cumbersome transcription
of paper-based tools. Central data storage allow for
prospective data collection and aggregation from dif-
ferent centers. Novel study designs can be initiated
that overcome limitations of conventional randomized
controlled clinical trials, e.g., comparative (real world)
effectiveness studies [62–65]. Biopsychosocial pheno-
types identified through research can be used in clin-
ical practice for more refined screening and more
tailored management [66].
For health insurance carriers and other third-party fi-
nancing agents, personalized health contributes directly
to cost savings, but also indirectly by reducing the risk
of chronicity.
Finally, wide implementation of the WISE will aid
to adequately and comprehensibly incorporate psycho-
social entities in classification systems rooted in an
ontological framework based on analysis of symptom
clusters [67–72].
The WISE is extensible: the composition of symptom
burden checklist items and/or case finding instruments
can be modified, depending on the needs of a given
clinic, e.g., for more detailed exploration of obstructive
sleep apnea, halitosis, xerostomia, dysphagia, etc.
Limitations
There are limitations of web-based instruments: Com-
pared to paper-based versions, completing electronic
questionnaires is more time consuming and some people
may require assistance. With increasing familiarity with
electronic devices, this problem will likely diminish. In the
context of clinical trials, most patients prefer electronic
data collection methods [16]. Whether the web-based
Fig. 6 Example of a single case summary report
Ettlin et al. The Journal of Headache and Pain  (2016) 17:77 Page 12 of 15
administration significantly decreases patient burden and
increases compliance will require further evaluation.
In this paper, the WISE symptom domains were se-
lected for a single interdisciplinary OFP and TMD care
team in Zurich. Future studies are warranted to clarify
the validity of the chosen symptom burden checklist
structure. We opted for the above mentioned case-
finding questionnaires based on the following priority
sequence: free availability > brevity > robust psychometric
properties in the primary care setting. This choice was
an arbitrary decision by the authors and not based on an
international expert panel recommendation.
The WISE was designed to assist clinical decision
making. Whether it also has psychometric validity re-
quires further testing. Also, determination of the optimal
thresholds for opening a case-finding instrument needs
further clarification. Further, the utility of the instrument
to detect change over time for determining treatment
effects will need to be clarified. Our planned future re-
search will focus on these issues.
The current version of the WISE uses seven vertical
rulers for obtaining a general impression of the diurnal
pain course. This is a common limitation of electronic data
gathering compared to a pencil-paper approach where
pain courses can easily be drawn. Also fluctuating pain
patterns cannot be captured by this tool. Still, we estimate
that the combination of the diurnal pain course combined
with the general pain pattern will offer an initial impres-
sion of most clinically relevant pain patterns. However, this
assumption will require future scientific assessment.
The WISE for OFP and TMD is only one part of an in-
tegral patient evaluation that also includes an interview,
physical examination, imaging, laboratory tests, other ex-
pert evaluations, etc. How all these additional data can be
integrated in a comprehensive patient database remains to
be explored.
Conclusions
The WISE is a novel web-based tool that assists clini-
cians in clarifying case complexity and referral need,
based on symptom burden and response –tailored case
finding. It provides single-case summary reports from a
biopsychosocial perspective and includes graphical
symptom maps. Secure, centrally stored data collection
of anonymous data is possible. The tool enables person-
alized medicine, facilitates interprofessional education
and collaboration, and allows for multicenter patient-
reported outcomes research.
Summary
We presented the design, construction, and technical
implementation of a web-based instrument for interdis-
ciplinary evaluation of symptom burden, illustrated for
OFP and TMD.
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